Cybin is a biotech company developing mental health therapeutics leveraging the proven benefits of psychedelic compounds to dramatically improve patient outcomes versus currently available pharmacotherapies. NYSE: CYBN and Toronto NEO: CYBN
3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here or